Previous 10 | Next 10 |
Invitae (NYSE:NVTA) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close. The consensus EPS Estimate is -$0.77 (-22.2% Y/Y) and the consensus Revenue Estimate is $125.9M (+25.4% Y/Y). Over the last 2 years, NVTA has beaten EPS estimates 25% of the time a...
Invitae Launches its First CE-IVD Cancer Testing Kits In Europe - New in-vitro diagnostic kits help patients fight cancer in the EU - PR Newswire SAN FRANCISCO , Feb. 16, 2022 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, toda...
Invitae to Announce Fourth Quarter and Full Year 2021 Financial Results on Thursday, February 24, 2022 PR Newswire SAN FRANCISCO , Feb. 10, 2022 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will...
Shares of Invitae Corporation are down some 80% in the past twelve months as its acquisition strategy and operational cash burn show no signs of abating. Operational cash outflow exceeded revenue during the first nine months of 2021, indicating that its highly dilutive acquisition str...
Invitae to Present at Upcoming Investor Conferences PR Newswire SAN FRANCISCO , Feb. 3, 2022 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in...
Invitae Supports the Biden Administration's Advancement of the Cancer Moonshot, Enhanced Recommendations on Genetic Testing for Cancer Treatment -- Recommendations include assessment of eligibility for germline genetic testing for all people diagnosed with cancer -- PR Newsw...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Strategy outperformance in the quarter and the year was d...
Cathie Wood’s flagship fund, the ARK Innovation ETF (ARKK), gained in triple digit percentage terms during 2020, which propelled her to widespread notoriety. However, in 2021 the fund declined. Furthermore, short interest against ARKK has increased, and bets against her other funds are...
Cathie Wood’s ARK ETFs are significantly down this year. Wood’s holdings Roblox (RBLX) and Invitae (NVTA) have plunged over the past few months and we believe more downside in the months ahead. Cathie Wood, the founder and CEO of investment company ARK Invest rose to widesp...
Invitae Reports Preliminary 2021 Revenue of More Than $458 Million and Billable Volume of More Than 1.16 Million - 64 percent growth year-over-year in revenues - 76 percent growth year-over-year in billable volumes - Ended the year with more than 17,500 active healthcare...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...